Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ROAD
|
Judson Ryan Brooks
Senior Vice President, Legal |
BUY
Grant, award, or other acquisition
|
Direct | 1,970 Added 6.75% |
-
|
Oct 17
2025 |
|
AGEN
|
Garo H Armen |
BUY
Grant, award, or other acquisition
|
Direct | 4,216 Added 1.45% |
$16,358
$3.88 p/Share
|
Oct 17
2025 |
|
INTA
|
John T Hall
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,890 Added 0.17% |
$73,680
$7.45 p/Share
|
Oct 17
2025 |
|
ACRV
|
Mary Miller
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 558 Reduced 1.58% |
$1,009
$1.81 p/Share
|
Oct 17
2025 |
|
FRPT
|
Ivan Garcia
Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 23.95% |
-
|
Oct 17
2025 |
|
CLOV
|
Jamie L. Reynoso
CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct | 16,514 Reduced 0.56% |
$44,422
$2.69 p/Share
|
Oct 17
2025 |
|
XPON
|
Shawna Lee Bowin
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 48.93% |
-
|
Oct 17
2025 |
|
AOSL
|
Yifan Liang
CFO and Corp Secretary |
SELL
Bona fide gift
|
Direct | 300 Reduced 0.11% |
-
|
Oct 17
2025 |
|
NTRS
|
Alexandria Taylor
Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,823 Reduced 8.71% |
$471,872
$123.43 p/Share
|
Oct 17
2025 |
|
LAW
|
Thomas F Bogan
Director |
BUY
Open market or private purchase
|
Direct | 17,902 Added 10.23% |
$106,337
$5.94 p/Share
|
Oct 17
2025 |
|
TMUS
|
Telekom Ag Deutsche |
SELL
Open market or private sale
|
Direct | 64,426 Reduced 0.01% |
$14,732,293
$228.67 p/Share
|
Oct 17
2025 |
|
APOG
|
Brent C Jewell
President, Architectural Glass |
SELL
Payment of exercise price or tax liability
|
Direct | 542 Reduced 1.87% |
$20,596
$38.0 p/Share
|
Oct 17
2025 |
|
APOG
|
Troy R Johnson
Pres, Architectural Services |
BUY
Grant, award, or other acquisition
|
Direct | 8,553 Added 14.99% |
$325,014
$38.0 p/Share
|
Oct 17
2025 |
|
APOG
|
Matthew Sean Christian
President, Architectural Serv |
BUY
Grant, award, or other acquisition
|
Direct | 5,679 Added 27.1% |
$215,802
$38.0 p/Share
|
Oct 17
2025 |
|
STKL
|
David J Lemmon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,310 Added 20.09% |
$7,440
$5.68 p/Share
|
Oct 17
2025 |
|
STKL
|
Mahes Wickramasinghe
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,521 Added 3.06% |
$8,639
$5.68 p/Share
|
Oct 17
2025 |
|
STKL
|
Diego Reynoso
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,529 Added 6.02% |
$20,044
$5.68 p/Share
|
Oct 17
2025 |
|
STKL
|
Rebecca Fisher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,913 Added 1.35% |
$10,865
$5.68 p/Share
|
Oct 17
2025 |
|
STKL
|
Leslie Starr Keating
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,355 Added 5.05% |
$41,776
$5.68 p/Share
|
Oct 17
2025 |
|
STKL
|
Albert D. Bolles
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,806 Added 0.78% |
$10,258
$5.68 p/Share
|
Oct 17
2025 |
|
VOCO
|
Paul Richard Taylor
Chairman and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 110,435,624 Added 4.61% |
-
|
Oct 17
2025 |
|
CLBK
|
Thomas J. Kemly
President & CEO |
BUY
Grant, award, or other acquisition
|
Indirect | 130 Added 0.0% |
$1,784
$13.73 p/Share
|
Oct 17
2025 |
|
CLBK
|
John Klimowich
SEVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 46 Added 0.0% |
$631
$13.73 p/Share
|
Oct 17
2025 |
|
CLBK
|
Allyson Katz Schlesinger
SEVP&Head of Consumer Banking |
BUY
Grant, award, or other acquisition
|
Indirect | 24 Added 0.0% |
$329
$13.73 p/Share
|
Oct 17
2025 |
|
DLTR
|
Robert Aflatooni
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 1,260 Reduced 5.56% |
$119,322
$94.7 p/Share
|
Oct 17
2025 |
|
IGC
|
Claudia Grimaldi
PFO |
SELL
Bona fide gift
|
Direct | 50,000 Reduced 4.22% |
-
|
Oct 17
2025 |
|
SCYX
|
Gonzalez David Angulo
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 32,500 Added 3.67% |
$24,700
$0.76 p/Share
|
Oct 17
2025 |
|
STKL
|
Richard Dean Hollis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,529 Added 0.6% |
$20,044
$5.68 p/Share
|
Oct 17
2025 |
|
KEYS
|
Jeffrey K Li
SVP and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 2,982 Added 8.12% |
-
|
Oct 17
2025 |
|
KEYS
|
Jo Ann Juskie
SVP |
BUY
Grant, award, or other acquisition
|
Direct | 2,982 Added 24.03% |
-
|
Oct 17
2025 |
|
SION
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect | 61,124 Reduced 0.0% |
$2,002,422
$32.76 p/Share
|
Oct 17
2025 |
|
NVDA
|
Jen Hsun Huang
President and CEO |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 0.11% |
$13,677,750
$182.37 p/Share
|
Oct 17
2025 |
|
MARA
|
Frederick G Thiel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 27,505 Reduced 0.73% |
$538,272
$19.57 p/Share
|
Oct 17
2025 |
|
IGC
|
Ram Mukunda
CEO |
SELL
Bona fide gift
|
Direct | 100,000 Reduced 2.44% |
-
|
Oct 17
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 131,680 Reduced 0.4% |
$55,305
$0.42 p/Share
|
Oct 17
2025 |
|
BYSI
|
Decheng Capital China Life Sciences Usd Fund Iii, L.P. |
SELL
Open market or private sale
|
Indirect | 45,513 Reduced 0.0% |
$80,102
$1.76 p/Share
|
Oct 17
2025 |
|
GH
|
Medina Manuel Hidalgo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 232 Added 15.0% |
-
|
Oct 17
2025 |
|
GH
|
Myrtle S Potter
Director |
SELL
Open market or private sale
|
Direct | 26 Reduced 0.14% |
$1,740
$66.95 p/Share
|
Oct 17
2025 |
|
GH
|
Musa Tariq
Director |
SELL
Open market or private sale
|
Direct | 116 Reduced 1.48% |
$7,766
$66.95 p/Share
|
Oct 17
2025 |
|
GBX
|
Lorie Tekorius
CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct | 3,506 Reduced 1.33% |
$159,417
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Matthew Joseph Meyer
SVP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 310 Reduced 4.83% |
$14,095
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Christian Lucky
SVP, CLO and CCO |
SELL
Payment of exercise price or tax liability
|
Direct | 504 Reduced 4.34% |
$22,916
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
William J. Krueger
SVP, COO, The Americas |
SELL
Payment of exercise price or tax liability
|
Direct | 1,020 Reduced 3.12% |
$46,379
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
William Glenn
SVP & President, Europe |
SELL
Exercise of conversion of derivative security
|
Direct | 2,701 Reduced 8.93% |
-
|
Oct 17
2025 |
|
GBX
|
Laurie R Dornan
SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 483 Reduced 1.6% |
$21,962
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Michael J Donfris
SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 724 Reduced 4.25% |
$32,920
$45.47 p/Share
|
Oct 17
2025 |
|
GBX
|
Brian J Comstock
EVP & President, The Americas |
SELL
Payment of exercise price or tax liability
|
Direct | 1,666 Reduced 4.62% |
$75,753
$45.47 p/Share
|
Oct 17
2025 |
|
PRTS
|
Ryan Lockwood
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,709 Reduced 3.12% |
$4,427
$0.66 p/Share
|
Oct 17
2025 |
|
JNJ
|
John C Reed
EVP, Innovative Medicine, R&D |
SELL
Open market or private sale
|
Direct | 21,721 Reduced 67.08% |
$4,185,853
$192.71 p/Share
|
Oct 17
2025 |
|
JNJ
|
John C Reed
EVP, Innovative Medicine, R&D |
BUY
Exercise of conversion of derivative security
|
Direct | 21,721 Added 40.15% |
$3,430,180
$157.92 p/Share
|
Oct 17
2025 |